Twente, Netherlands

Raymond Zeeman


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 246(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Raymond Zeeman

Introduction

Raymond Zeeman is a notable inventor based in Twente, Netherlands. He has made significant contributions to the field of bioprosthetic devices, particularly through his innovative patent. His work focuses on enhancing the functionality and effectiveness of medical implants.

Latest Patents

Raymond Zeeman holds a patent for a "Process for making a bioprosthetic device and implants produced therefrom." This patent describes bioprosthetic devices made of collagen-based material that feature collagen amine groups and collagen carboxyl groups. The methods outlined in the patent involve combining an epoxy functionalized crosslinking agent with the collagen-based material in an aqueous medium at an acidic pH. This process allows for the reaction of a portion of the collagen carboxyl groups with the crosslinking agent, resulting in crosslinked collagen-based material that retains residual collagen carboxyl groups.

Career Highlights

Raymond Zeeman is associated with Medtronic, Inc., a leading company in the medical technology sector. His work at Medtronic has allowed him to focus on the development of advanced bioprosthetic solutions that can improve patient outcomes.

Collaborations

Raymond has collaborated with notable colleagues, including Marc Hendriks and Michel L Verhoeven. These collaborations have contributed to the advancement of his research and the successful development of innovative medical devices.

Conclusion

Raymond Zeeman's contributions to the field of bioprosthetic devices exemplify the importance of innovation in medical technology. His patent and work at Medtronic highlight his commitment to improving healthcare through advanced materials and methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…